moxifloxacin has been researched along with Bradyarrhythmia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eusebio, J; Farhoumand, AD; Trombert, V | 1 |
| Absi, M; Ghareeb, H; Khalil, A; Ruegg, UT | 1 |
| Akyurek, O; Altin, T; Guldal, M; Karaoguz, R; Ongun Ozdemir, A; Ozcan, O; Turhan, S | 1 |
| Delesen, H; Kubitza, D; Rink, AD; Stass, H; Vestweber, KH | 1 |
1 trial(s) available for moxifloxacin and Bradyarrhythmia
| Article | Year |
|---|---|
Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Area Under Curve; Aza Compounds; Body Fluids; Bradycardia; Drainage; Female; Fluoroquinolones; Half-Life; Humans; Injections, Intravenous; Kinetics; Male; Middle Aged; Moxifloxacin; Quinolines; Time Factors; Tissue Distribution; Tomography, X-Ray Computed | 2008 |
3 other study(ies) available for moxifloxacin and Bradyarrhythmia
| Article | Year |
|---|---|
[Practical ECG problems in the elderly patient. Case number 16. Moxifloxacin-associated QT interval prolongation].
Topics: Aged, 80 and over; Anti-Arrhythmia Agents; Anti-Infective Agents; Atenolol; Aza Compounds; Bradycardia; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Quinolines | 2011 |
The effect of levofloxacin and moxifloxacin on cardiovascular functions of rats with streptozotocin-induced diabetes.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Biological Factors; Blood Glucose; Bradycardia; Cardiovascular System; Diabetes Mellitus, Experimental; Electrocardiography; Endothelium, Vascular; Fluoroquinolones; Heart; Heart Rate; Hypoglycemia; Intermediate-Conductance Calcium-Activated Potassium Channels; Levofloxacin; Male; Mesenteric Arteries; Moxifloxacin; Ofloxacin; Quinolines; Rats; Rats, Wistar; Small-Conductance Calcium-Activated Potassium Channels; Streptozocin | 2013 |
Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event.
Topics: Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bradycardia; Cardiac Pacing, Artificial; Female; Fluoroquinolones; Humans; Long QT Syndrome; Moxifloxacin; Pneumonia; Quinolines; Risk Factors; Syncope; Torsades de Pointes; Treatment Outcome | 2007 |